ERBB2 and breast carcinoma: While HER2-negative breast cancer typically denotes tumors that lack HER2 overexpression, this statement has recently been slightly expanded, and it has been reclassified into three new subgroups: HER2-null, HER2-ultralow, and HER2-low.